Patent holdings for IPC class A61K 31/5025

Total number of patents in this class: 2370

10-year publication summary

119
145
154
150
204
188
187
218
256
135
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4892
58
F. Hoffmann-La Roche AG
7926
39
Novartis AG
10904
38
Janssen Pharmaceutica N.V.
3423
35
Takeda Pharmaceutical Company Limited
2704
32
Genentech, Inc.
3961
30
Gilead Sciences, Inc.
2028
30
AstraZeneca AB
2928
27
Boehringer Ingelheim International GmbH
4704
27
Nihon Nohyaku Co., Ltd.
318
25
Agios Pharmaceuticals, Inc
218
23
Pfizer Inc.
3367
21
Hoffmann-La Roche Inc.
3379
20
Vanderbilt University
1887
20
Amgen Inc.
4047
19
Merck Sharp & Dohme LLC
3741
18
Remix Therapeutics Inc.
79
17
Bayer Pharma AG
1061
16
Incyte Corporation
1011
16
Merck Patent GmbH
5850
15
Other owners 1844